Cell therapy boost: Hitachi Chemical expands CDMO site in New Jersey, US

By Flora Southey contact

- Last updated on GMT

Hitachi Chemical is expanding manufacturing and cleanroom capacity at its cell therapy-focused CDMO site in Allendale, New Jersey, US.

The expansion will see Hitachi Chemical Advanced Therapeutics Solutions (HCATS) add 49,700 sq. ft. to its contract development and manufacturing organisation’s (CDMO) branch, PCT.

The site will house manufacturing development labs, quality control and microbiology labs, additional Grade B/ISO 7 cleanrooms, warehousing and office space.

Validation for the facility is planned before the end of 2018.

The firm said it expects the expansion to attract new business to PCT.

“HCATS anticipates that the increase in demand for cell therapy development and manufacturing services will result in substantial growth of the company’s employee base in the company year,” ​said the company.

Pearl Court & Yokohama upgrades

The firm also announced plans to upgrade its Pearl Court site in Allendale, and said its regenerative cell-focused CDMO site in Yokohama, Japan, which is under construction, will be validated by April, 2018.

Hitachi Chemical Co. America – the US off-shoot of Japan-based Hitachi Chemical – purchased​ PTC from majority shareholder Caladrius Biosciences earlier this year.

Related news

Related products

show more


Inline diafiltration enables continuous processing

Pall Life Sciences | 13-Feb-2018 | Application Note

The Cadence inline diafiltration (ILDF) device is designed for continuous processing, in-process buffer exchange or contaminant removal in various processes...

Discover Fast and Simple Water Intrusion Testing

Discover Fast and Simple Water Intrusion Testing

Pall Life Sciences | 13-Nov-2017 | Application Note

At Pall we have supported the water intrusion test for more than 20 years and we developed the Palltronic® AquaWIT IV system to deliver fast and simple...

Think all buffer filters are the same?

Think all buffer filters are the same?

Pall Life Sciences | 01-Nov-2017 | Application Note

Pall’s Supor ® buffer filters are designed for high flow rates and rapid microbial removal. This can mean dramatic reductions in buffer handling costs...

Related suppliers